Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Instagram
THOR on YouTube
“Each attendance brings something new to think about as our own learning process and experience is evolving. It is always a pleasure to hear about new applications. James has the gift of bringing complicated material in a comprehensive way and adapts his lecture to the need of the group. ”
Beatrijs Deruyter, LTH, MSc, PhDs
Private Dental Practice
Liedekerke, Belgium
View current photobiomodulation therapy training dates in your location.
Dr Roberta Chow PhD and Lydia Feng talk about the use of light and lasers for relief of chronic pain. The THOR handheld unit and NovoTHOR light-pod can be used to reduce the need for medication and delay the need for surgery without any side-effects.
View current photobiomodulation therapy training dates in your location.
“Compliment to the training and work you do. It’s making me feel very motivated for my work with my veterinary THOR! Thank you again!”
Gina Voglar
Doctor of Veterinary Medicine
HouseCallVet
Auckland, New Zealand
View current photobiomodulation therapy training dates in your location.
Arash Jafari, a client of Laser Therapy Sydney talks about the use of the NovoTHOR LED light bed to relieve the fatigue caused by Lyme Disease.
More NovoTHOR Testimonials | NovoTHOR Treatment Locations
View current photobiomodulation therapy training dates in your location.
Dimitra, a Sydney dentist uses the NovoTHOR light bed at Laser Therapy Sydney to relieve the pain from multiple injuries including whiplash, back pain, a torn wrist ligament and a sprained ankle.
More NovoTHOR Testimonials | NovoTHOR Treatment Locations
View current photobiomodulation therapy training dates in your location.
SEATTLE, June 12, 2019 /PRNewswire/ — LumiThera, Inc. and Product Creation Studio today announced that LumiThera’s Valeda Light Delivery System has been honored with a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2019 in conjunction with the MD&M East event in New York, New York.
LumiThera, Inc. is a leader in the use of photobiomodulation for the treatment of acute and chronic ocular diseases and disorders. Age-related macular degeneration (AMD) is the leading cause of blindness in adults over 65. Product Creation Studio worked with LumiThera from product concept through transfer to manufacturing to design and engineer a medical device that would accurately, safely, and effectively treat patients suffering from dry AMD. The resulting Valeda Light Delivery System is currently the only approved treatment using Photobiomodulation for dry age-related macular degeneration in the European Union.
The MDEA are the medtech industry’s premier design competition committed to recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. The awards program celebrates the accomplishments of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives; improving patient healthcare; and transforming medtech—one innovation at a time.
“This award recognizes the efforts of the LumiThera and the Product Creation teams who have worked diligently to deliver a life changing treatment for those suffering from dry AMD,” said Clark Tedford, PhD, CEO and President. “We are pleased to bring the Valeda Light Delivery System to the ophthalmic market and offer dry AMD patients a treatment for this debilitating disease.”
“Product Creation Studio’s collaboration with LumiThera embodies what our organization is about: empowering innovators with the right design and development services at the right time to deliver products with impact,” Scott Thielman, Chief Technology officer of Product Creation Studio, said. “The Valeda Light Delivery System is a breakthrough product that makes a meaningful difference for patients and their families. It has been an honor to support the LumiThera team with comprehensive engineering and design services from the company’s early days through production.”
The 2019 MDEA Juror Panel selected 44 exceptional finalists in nine medical technology product categories. Products were judged based on design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. Unlike other design competitions that are merely styling contests, the MDEA jury is comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts.
View the press release on Lumithera website at www.lumithera.com
Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.
“We had a really good time during the THOR training course in São Paulo. It was a chance not only to learn a lot about PBMT, but especially about the scientific basis of light therapy and how to conduct a training course in the fields of Medicine and Dentistry.
Mr. Carroll is fantastic and quite inspiring. We can’t thank the THOR Laser team enough.”
Dr. Alan Roger Santos-Silva
Associate Professor in Oral Medicine and Oral Pathology
Piracicaba Dental School
University of Campinas (Unicamp), Brazil
View current photobiomodulation therapy training dates in your location.
UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates